Literature DB >> 9231669

Potential role of proton therapy in the treatment of pediatric medulloblastoma/primitive neuroectodermal tumors: reduction of the supratentorial target volume.

R Miralbell1, A Lomax, T Bortfeld, M Rouzaud, C Carrie.   

Abstract

PURPOSE: One of the components of radiotherapy (RT) in medulloblastoma/primitive neuroectodermal tumors is the prophylactic irradiation of the whole brain (WBI). With the aim of reducing late neuropsychologic morbidity a CT-scan-based dosimetric study was undertaken in which treatment was confined mainly or exclusively to supratentorial sites considered at high risk for disease recurrence. METHODS AND MATERIALS: A comparative dosimetric study is presented in which a three field (two laterals and one posterior) proton plan (spot scanning method) is compared with a two-field conventional WBI 6 MV x-ray plan, to a 6-field "hand-made" 6 MV x-ray plan, and to a computer-optimized 9-field "inverse" 15 MV x-ray plan. For favorable patients, 30 Gy were delivered to the ventricles and main cisterns, the subfrontal and subtemporal regions, and the posterior fossa. For the unfavorable patients, 10 Gy WBI preceeded a boost to 30 Gy to the same treatment volume chosen for favorable patients. The dose distribution was evaluated with dose-volume histograms to examine the coverage of the targets as well as the dose to the nontarget brain and optical structures. In addition, the risks of radiation-related late neuropsychologic effects after WBI were collected from the literature and used to predict normal tissue complication probabilities (NTCPs) for an intelligence quotient deficit after treatment with photon or proton beams.
RESULTS: Proton beams succeeded better in reducing the dose to the brain hemispheres and eye than any of the photon plans. A 25.1% risk of an IQ score <90 was predicted after 30 Gy WBI. Almost a 10% drop in the predicted risk was observed when using proton beams in both favorable and unfavorable patients. However, predicted NTCPs for both optimized photon plans ("hand made" and "inverse") were only slightly higher (0.3-2.5%) than those of proton beams. An age-modifying factor was introduced in the predictive NTCP model to assess for IQ differences in relation with age at irradiation. Children with ages between age 4 to 8 benefitted most from the dose reduction in this exercise (similar NTCP predictions for both proton and "inverse" plans).
CONCLUSION: Modulated proton beams may help to significantly reduce the irradiation of normal brain while optimally treating the supratentorial subsites at higher risk for relapse. A decrease in morbidity can be expected from protons and both optimized proton plans compared to WBI.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9231669     DOI: 10.1016/s0360-3016(97)00004-7

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  13 in total

1.  [HIT'91: Precision and acute maximal side effects of radiotherapy of craniospinal axis. Concerning the contribution by R.D. Kortmann et al., Strahlenther Onkol 1999;175:162-9 (No.4)].

Authors:  E Weiss; C F Hess
Journal:  Strahlenther Onkol       Date:  1999-05       Impact factor: 3.621

Review 2.  Treatment developments and the unfolding of the quality of life discussion in childhood medulloblastoma: a review.

Authors:  Thora Gudrunardottir; Birgitta Lannering; Marc Remke; Michael D Taylor; Elizabeth M Wells; Robert F Keating; Roger J Packer
Journal:  Childs Nerv Syst       Date:  2014-02-26       Impact factor: 1.475

Review 3.  Pediatric papillary tumors of the pineal region: to observe or to treat following gross total resection?

Authors:  Lucia Abela; Elisabeth Jane Rushing; Carmen Ares; Ianina Scheer; Oliver Bozinov; Eugen Boltshauser; Michael A Grotzer
Journal:  Childs Nerv Syst       Date:  2012-10-06       Impact factor: 1.475

Review 4.  Proton therapy for the treatment of children with CNS malignancies.

Authors:  Radhika Sreeraman; Daniel J Indelicato
Journal:  CNS Oncol       Date:  2014-03

5.  Technique, outcomes, and acute toxicities in adults treated with proton beam craniospinal irradiation.

Authors:  Christian L Barney; Aaron P Brown; David R Grosshans; Mary Frances McAleer; John F de Groot; Vinay Puduvalli; Susan L Tucker; Cody N Crawford; Mark R Gilbert; Paul D Brown; Anita Mahajan
Journal:  Neuro Oncol       Date:  2013-12-04       Impact factor: 12.300

6.  Comparison of risk of radiogenic second cancer following photon and proton craniospinal irradiation for a pediatric medulloblastoma patient.

Authors:  Rui Zhang; Rebecca M Howell; Annelise Giebeler; Phillip J Taddei; Anita Mahajan; Wayne D Newhauser
Journal:  Phys Med Biol       Date:  2013-01-16       Impact factor: 3.609

Review 7.  Clinical controversies: proton therapy for pediatric tumors.

Authors:  Thomas E Merchant
Journal:  Semin Radiat Oncol       Date:  2013-04       Impact factor: 5.934

8.  Hepatic Sinusoidal Obstruction Syndrome in a child after chemotherapy for medulloblastoma.

Authors:  M Kashif Ishaqi; A Jamil; M Khanani; M Baroudi; Omar Trad; M El-Hayek; Eric Bouffet
Journal:  J Neurooncol       Date:  2009-08-23       Impact factor: 4.130

9.  Stray radiation dose and second cancer risk for a pediatric patient receiving craniospinal irradiation with proton beams.

Authors:  Phillip J Taddei; Dragan Mirkovic; Jonas D Fontenot; Annelise Giebeler; Yuanshui Zheng; David Kornguth; Radhe Mohan; Wayne D Newhauser
Journal:  Phys Med Biol       Date:  2009-03-20       Impact factor: 3.609

10.  Comparison of therapeutic dosimetric data from passively scattered proton and photon craniospinal irradiations for medulloblastoma.

Authors:  Rebecca M Howell; Annelise Giebeler; Wendi Koontz-Raisig; Anita Mahajan; Carol J Etzel; Anthony M D'Amelio; Kenneth L Homann; Wayne D Newhauser
Journal:  Radiat Oncol       Date:  2012-07-24       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.